Latest

The MarketReader Minute

๐Ÿ’Š Biotech Sector Faces Mixed Reactions as Beigene, Zai Lab, Alnylam, and Vaxcyte Report Results Amid Downgrades and Regulatory Developments | Biotech Sector Insights

(IBB) has experienced a decline of 1.1% since Monday. Recent social media discussions highlighted a study showing that a portion of Asian women diagnosed with lung cancer had never smoked, linking this to advancements by Lantern Pharma in utilizing artificial intelligence for cancer treatment.

lock-1